Musculoskeletal Pain
📧 Sign up to get email alerts when something new happens for Musculoskeletal Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Pain in America: A Randomized Controlled Trial [NA]
A randomized controlled trial studying musculoskeletal pain conducted by the University of Missouri, Kansas City has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain [NA]
The GET Living graded exposure treatment trial for children and adolescents with chronic pain has completed, according to Boston Children's …
-
FDA approval · 2018-03-13FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for cyclobenzaprine hydrochloride (Upsher-Smith Laboratories, LLC).
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Traumatic Musculoskeletal Pain [Phase 4]
A Phase 4 trial comparing intravenous paracetamol and dexketoprofen for acute traumatic musculoskeletal pain has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Immediate Effect of Energy Alignment and Mantra on Stress Related Pain in Adolescents [NA]
Clinical trial NCT03308630 has completed a study evaluating the immediate effect of energy alignment and mantra on stress-related pain in ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-08-31FDA Approved: METAXALONE — Original Application (BluePoint Laboratories)
FDA approved the original application for metaxalone as a generic (ANDA 207466) manufactured by BluePoint Laboratories for relief of muscle …
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Chronic Low Back Pain Rehabilitation in Primary Care: an RCT [NA]
This entry reports the completion of a randomized controlled trial evaluating rehabilitation for chronic low back pain in primary care. No r…
-
CLINICAL_TRIALS withdrawal · 2017-07-28Clinical Trial Update: Acupuncture for Pain in the Emergency Department [EARLY_Phase 1]
EARLY Phase 1 clinical trial evaluating acupuncture for pain in the emergency department has been withdrawn (NCT02540512).
-
FDA approval · 2017-07-21FDA Approved: METHOCARBAMOL — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved the original application for a generic methocarbamol product from UNICHEM Pharmaceuticals (USA), Inc.
-
FDA approval · 2017-07-18FDA Approved: METHOCARBAMOL — Original Application (Sagent Pharmaceuticals)
The FDA approved Sagent Pharmaceuticals’ original application for methocarbamol (generic). It covers its use as a muscle-relaxant for short-…
-
FDA approval · 2017-06-15FDA Approved: METAXALONE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s generic Metaxalone under an Original Application for relief of muscle spasm associated with musculoskele…
-
CLINICAL_TRIALS research · 2017-06-01Clinical Trial Update: Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management
An observational study sponsored by Proove Bioscience evaluating how genetic testing influences decision-making and care in interventional p…
-
FDA approval · 2017-05-31FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Original Application (Advagen Pharma Limited)
FDA approved Cyclobenzaprine hydrochloride as an original application generic product manufactured by Advagen Pharma Limited.
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Osteopathy, Mindfulness and Acceptance-based Programme for Patients With Persistent Pain
This entry documents the completion of a trial evaluating an Osteopathy, Mindfulness and Acceptance-based Programme for patients with persis…
-
FDA approval · 2017-05-18FDA Approved: DULOXETINE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original application for duloxetine, enabling the marketing of a generic duloxetine product.
-
FDA approval · 2017-05-11FDA Approved: CARISOPRODOL — Original Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals, LLC's original application for Carisoprodol (generic) to treat short-term relief of discomfort…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Stepped Care for Depression and Musculoskeletal Pain [Phase 4]
Phase 4 trial update on a stepped-care approach for depression and musculoskeletal pain; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Nontraumatic Musculoskeletal Pain [Phase 4]
Phase 4 clinical trial comparing intravenous paracetamol to dexketoprofen for acute nontraumatic musculoskeletal pain has completed.
-
FDA approval · 2017-04-13FDA Approved: PIROXICAM — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Unichem Pharmaceuticals (USA), Inc.'s Original Application for piroxicam, authorizing a generic version of the NSAID piroxicam.
-
FDA approval · 2017-03-23FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for duloxetine hydrochloride from Macleods Pharmaceuticals Limited, authorizing a generic version of d…
-
CLINICAL_TRIALS research · 2017-02-23Clinical Trial Update: Testing the Characteristics of Platelet Rich Plasma in Sports Medicine
This clinical trial update reports on the characteristics of platelet-rich plasma used in sports medicine, focusing on musculoskeletal pain …
-
CLINICAL_TRIALS withdrawal · 2017-02-20Clinical Trial Update: Posturographic Characteristics of Eccentric, Isometric and Concentric Movements [NA]
The clinical trial NCT02577653 investigating posturographic characteristics of eccentric, isometric, and concentric movements in chronic and…
-
FDA approval · 2017-01-31FDA Approved: CARISOPRODOL — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Carisoprodol from Wilshire Pharmaceuticals, Inc., granting approval to market a generic vers…
-
CLINICAL_TRIALS research · 2017-01-31Clinical Trial Update: Long Duration Therapeutic Ultrasound on Tendon Injuries [NA]
A clinical trial evaluating long-duration therapeutic ultrasound for tendon injuries and musculoskeletal pain has been terminated.
-
FDA approval · 2017-01-19FDA Approved: METHOCARBAMOL — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the original application for a generic methocarbamol product by Slate Run Pharmaceuticals, LLC.